Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotec for pain reduction in diabetic neuropathy
IRCT138705221044N1Phase 2Completed
- Sponsor
- Endocrinology and Metabolism Research Institute
- Start
- Aug 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Neurotec in diabetic neuropathy, sponsored by Endocrinology and Metabolism Research Institute. Started Aug 2008; status: completed.
02
Drugs
Neurotec
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT138705221044N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138705221044N1.